Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Clear all

237 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20014
20022
20036
20048
200511
200614
200712
200811
200913
201013
20114
201211
201315
201413
20157
20166
20178
20189
201911
20204
20216
202211
20239
20247
20254
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed131
Unknown status35
Terminated29
Recruiting21
Withdrawn8
Not yet recruiting7
Active, not recruiting4
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi11
Population Health Research Institute8
Biosense Webster, Inc.7
Meshalkin Research Institute of Pathology of Circulation7
Texas Cardiac Arrhythmia Research Foundation7
Advanz Pharma4
Bayer4
Astellas Pharma Inc3
AtriCure, Inc.3
Atrial Fibrillation Network3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation237
Stroke30
Arrhythmias, Cardiac25
Atrial Flutter18
Heart Diseases12
Heart Failure10
Hemorrhage8
Cardiovascular Diseases7
Thromboembolism6
Ischemic Stroke5

Trials

Showing 51 to 75 of 237. Each trial links to its page on Pharma Observatory.

137 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.